EARLY 3-Months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA

This study has been completed.

Study NCT00562588 Information provided by Boehringer Ingelheim Pharmaceuticals

First Received: July 6, 2007 Last Updated: March 5, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	February 2009 (Final data collection date for primary outcome measure)